Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]

David Hodgson,Neil Wilkins,Edwin van Leeuwen,Conall H Watson,Jonathan Crofts,Stefan Flasche,Mark Jit,Katherine E Atkins
DOI: https://doi.org/10.1016/j.lanepe.2024.101073
2024-09-11
Abstract:[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.].
What problem does this paper attempt to address?